Dakota Community Bank & Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Sell
1,441
-6
-0.4% -$1.18K 0.95% 33
2026
Q1
$284K Sell
1,447
-29
-2% -$5.63K 0.96% 34
2025
Q4
$256K Buy
1,476
+54
+4% +$9.83K 0.88% 35
2025
Q3
$271K Sell
1,422
-113
-7% -$20.1K 1.07% 31
2025
Q2
$276K Sell
1,535
-105
-6% -$18.2K 1.24% 26
2025
Q1
$277K Sell
1,640
-117
-7% -$19.2K 1.34% 27
2024
Q4
$265K Sell
1,757
-90
-5% -$14K 1.26% 26
2024
Q3
$287K Sell
1,847
-5
-0.3% -$747 1.44% 25
2024
Q2
$254K Buy
1,852
+108
+6% +$14.8K 1.36% 30
2024
Q1
$232K Buy
1,744
+367
+27% +$47.6K 1.26% 34
2023
Q4
$190K Buy
1,377
+25
+2% +$3.29K 1.06% 36
2023
Q3
$165K Sell
1,352
-6
-0.4% -$799 1.05% 35
2023
Q2
$191K Buy
1,358
+18
+1% +$2.48K 1.13% 32
2023
Q1
$190K Sell
1,340
-35
-3% -$5.01K 1.17% 33
2022
Q4
$215K Buy
1,375
+25
+2% +$3.59K 1.22% 25
2022
Q3
$166K Buy
+1,350
New +$178K 1.15% 37

Other funds holding DGX

Dakota Community Bank & Trust's DGX Position: Q2 2026 in Review

Dakota Community Bank & Trust reduced its Quest Diagnostics (DGX) stake by 0.41% in Q2 2026, selling an estimated $1.18K and leaving 1,441 shares worth $305K. The position accounts for 0.95% of the portfolio, ranked #33.

Dakota Community Bank & Trust first reported a position in DGX in Q3 2022 and has held it in 16 quarters since. 478 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Dakota Community Bank & Trust held 1,441 shares of Quest Diagnostics worth $305K as of Q2 2026.
  • Dakota Community Bank & Trust sold 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
  • Quest Diagnostics made up 0.95% of Dakota Community Bank & Trust's portfolio in Q2 2026, its #33 holding.
  • Dakota Community Bank & Trust first reported a position in Quest Diagnostics in Q3 2022 and has held it in 16 quarters since.
  • 478 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Dakota Community Bank & Trust's 13F filing for Q2 2026, filed 15 Jul 2026.